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Abstract
Background: Duration of peripheral nerve blocks depends on multiple factors. Both technique and type of local
anesthetic used, either with or without adjuncts, may result in different duration times of the block. The purpose of
the present study was to compare the duration of postoperative analgesia of 30 mL ropivacaine 0.75 % with or
without epinephrine for popliteal sciatic nerve block.
Methods: Thirty-eight patients were included to receive ultrasound guided continuous popliteal nerve block with
ropivacaine 0.75 % either without (ROPI) or with epinephrine 5 μg/mL (ROPI-EPI) for ankle fusion, subtalar fusion, or
a combination of both. The primary outcome parameter was the duration of postoperative analgesia as reflected by
the time to first request for postoperative analgesia (TTFR) through the popliteal nerve catheter. Secondary outcome
measures included the onset of sensory and motor block and NRS score for pain at rest and during movement.
Results: Thirty patients, 15 in each group, were studied. Eight patients were withdrawn because of specific withdrawal
criteria described in the protocol and replaced according to their group allocation. Median [interquartile range] TTFR
was 463 [300–1197] min and 830 [397–1128] min for the ROPI vs ROPI-EPI group respectively. Hodges Lehman median
difference between groups was 71 min (95 % CI −415 – 473 min). There was no difference in any clinical outcome
measure between the groups.
Conclusion: The results of this study did not show any significant increase in the duration of postoperative analgesia
by adding epinephrine to ropivacaine for popliteal nerve block. This may be due to the intrinsic vasoconstrictive
properties of ropivacaine. The absence of a significant difference can also be the result of a type II error caused
by a large variation in the individual TTFR.
Trial registration: Trial register.nl identifier: NTR3330, keyword TTFR
Keywords: Peripheral nerve block, Local anesthetic adjuncts, Postoperative analgesia
Background
Duration of peripheral nerve block depends on several
factors such as the choice of local anaesthetic (LA), the
site of injection and the presence of adjuncts such as
clonidine or epinephrine. Epinephrine may be added to
(large) doses of local anaesthetics with the objective to
reduce the maximum plasma concentration [1] or to
act as a marker for inadvertent intravascular injection
[2]. The rationale for adding epinephrine to reduce the
maximum plasma concentration is local vasoconstric-
tion at the site of injection [3], thereby slowing absorp-
tion. A decrease in absorption increases the duration of
analgesia [4]. The literature however, is inconclusive
regarding this effect. Several studies find a decrease in
Cmax and an increase in tmax as result of adding epineph-
rine to ropivacaine for epidural [5, 6], caudal [7] or
regional [8] (thoracic paravertebral block) anaesthesia
confirming a decrease in absorption. However, others fail
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to confirm prolonged sensory block duration when
adding epinephrine to ropivacaine [9, 10]. In a recent
study aimed to describe the pharmacokinetic profile of
high dose ropivacaine with and without epinephrine
[11], we found an indication of prolonged time to first
request for postoperative analgesia (TTFR) after the
addition of epinephrine to ropivacaine for combined sci-
atic/femoral nerve block for anterior cruciate ligament
reconstruction. In this study of 12 patients [11], 3 did not
request postoperative analgesia (1 in the ROPI-group and
2 in the ROPI-EPI-group). For the remaining patients the
median TTFR was 17 [12.5-22] h in the ROPI-EPI-group
and 3.5 [3–17] h in the ROPI-group. Because of the small
number of patients, these data have not been included in
the original publication.
The purpose of the present study is to compare the
duration of postoperative analgesia of 30 mL ropivacaine




This prospective double blinded (for observer and patient)
randomized study was approved by the Independent Re-
view Board Nijmegen (protocol number NL39628.072.12,
date of approval 28-02-2012) and was registered at http://
www.trialregister.nl (NTR3330, keyword TTFR) before
onset of participant enrolment. The study was conducted
at the Sint Maartenskliniek Nijmegen, The Netherlands
according to the Declaration of Helsinki and later revi-
sions thereof and in accordance with the ICH guidelines
for Good Clinical Practice.
Patients scheduled for continuous popliteal sciatic
nerve block for ankle fusion, subtalar fusion, or a com-
bination of both were assessed for eligibility during the
preoperative screening visit. Patients were informed
about the study verbally and in writing and written in-
formed consent was obtained from all patients. Eligible
participants were all adults aged 18 or over with ASA
physical health classification I-III. Exclusion criteria
included contra-indications for regional anaesthesia (in-
fection at the injection site, coagulopathy), known hyper-
sensitivity to amide-type local anaesthetics, known history
of peripheral neuropathy, inability to understand nu-
merical pain scales, and inability to operate a Patient-
Controlled Analgesia (PCA) device. Specific criteria for
withdrawal (and replacement) included: failure to per-
form adequate continuous popliteal sciatic nerve block;
pain in the distribution of the sciatic nerve upon arrival at
the recovery directly postoperatively requiring a thera-
peutic intervention (block failure); and failure to complete
the study protocol (e.g. no request for postoperative
analgesia).
Anaesthetic procedure
All patients received paracetamol 1000 mg orally three
times daily and etoricoxib 90 mg orally once a day, start-
ing on the morning of surgery for at least 7 days. Intraven-
ous access and routine monitoring were established in all
patients. Individuals were randomised by a computer-
generated random list in blocks of five and were concealed
in sequentially numbered, sealed, opaque envelopes pre-
pared by an independent investigator. The envelopes were
opened by an independent anesthetic nurse after partici-
pant details were written on the envelope. An assignment
card inside the envelope read either “30 mL ropivacaine
0.75 % without 5 μg/mL epinephrine” or “30 mL ropiva-
caine 0.75 % with 5 μg/mL epinephrine”. Accordingly,
patients received continuous popliteal nerve block with
ropivacaine either without (ROPI, n = 15) or with epineph-
rine (ROPI-EPI, n = 15). Study medication was disclosed
to the anesthesiologist performing the block procedure.
All popliteal blocks were placed with the patient in the
lateral decubitus position on the non-dependent side
using ultrasound guidance and a posterolateral in-plane
approach. A nerve stimulator set to deliver 100 nC (1 mA,
0.1 ms) at 2 Hz was used as an additional aid. The tibial,
peroneal and sciatic nerves were identified and injection
was made at the level of the bifurcation of the sciatic
nerve. Thirty mL ropivacaine 0.75 % without or with epi-
nephrine 5 μg/mL was injected in fractionated doses.
Time was designated t = 0 upon conclusion of the poplit-
eal sciatic nerve block. A perineural catheter was inserted
through the needle after injection of the loading dose.
Upon completion of the popliteal nerve block the patient
was placed in the supine horizontal position. Because
surgery was performed under exsanguination and a
tourniquet, a single shot ultrasound-guided femoral or
saphenous nerve block with 20 mL mepivacaine was
performed to facilitate the use of the tourniquet. Sur-
gery was performed under regional anaesthesia alone,
or supplemented with sedation upon patient request. If
the planned duration of surgery exceeded 120 min,
patients received general anaesthesia with propofol,
remifentanil and a laryngeal mask.
Upon arrival at the recovery room, a PCA-pump
(GemStar®, Hospira Inc. Lake Forest, Illinois, USA) was
connected to the popliteal catheter set up to deliver
bolus doses of 10 mL ropivacaine 0.2 %, with a lock-out
time of 15 min, no background infusion and a maximum
of 30 mL per 4 h. The intensity of postoperative pain was
evaluated by Numeric Rating Scale (NRS, 0–10 with 0
representing no pain and 10 worst possible pain). Prior to
surgery, patients had been instructed to use the PCA
device to maintain postoperative pain scores at or below
NRS 3. No regular postoperative opioids were provided. If
patients still needed pain medication after their first
request for ropivacaine through the popliteal catheter (ie
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after primary endpoint of the study), patients received
morphine 0.1–0.15 mg/kg every 4 h subcutaneously.
Clinical assessments
Baseline characteristics of participating patients were
recorded (i.e. age, length and weight).
During the first 45 min after performance of the pop-
liteal nerve block, a blinded observer assessed the onset
of sensory and motor block every 5 min until complete
block of the tibial and peroneal nerve. Sensory block of
the tibial and peroneal nerves was assessed by pinprick at
the heel of the foot (tibial nerve) and dorsum of the foot
between the 1st and 2nd toe (peroneal nerve). Sensory
block was scored on a three-point scale as 0 = absent, 1 =
partial and 2 = complete. Motor function of the tibial
(plantar flexion foot) and peroneal nerve (dorsal flexion of
foot) were also assessed on a three-point scale with 0 = no
motor block, 1 = partial and 2 = complete motor block.
Complete sensory and motor block was defined as a total
score of 8. In those patients that did not have a complete
block before the beginning of surgery, we assessed block
success upon arrival at the recovery room directly postop-
eratively. In these patients, block success was defined as
absence of pain requiring therapy in the distribution of
the sciatic nerve distribution area upon arrival at the
recovery room, whereas patients requiring pain relief at
this time were deemed failures and were excluded from
the study. Type and duration of surgery were recorded.
Because of the expected long duration of the sciatic
nerve block with ropivacaine, measuring the offset of
sensory and motor block similar to measuring the onset
would have implied frequent measurements during the
night. We considered this both unethical and impracti-
cal, therefore we did not measure offset, but chose the
TTFR as the primary outcome parameter reflecting the
duration of sensory sciatic nerve block/duration of anal-
gesia. At t = 24 h the PCA pump was read out and the
TTFR was noted. TTFR was defined as the time from t
= 0 until the time that the patient made the first request
for analgesia via the PCA pump. In case no request had
been made, the presence of sensory and/or motor block
were evaluated in the same manner as preoperatively. If
at this time patients who had made no request had no
signs of sensory sciatic nerve block, they were excluded
and replaced because of absence of the primary outcome
parameter. In case patients still showed signs of partial
or complete sciatic nerve block, the observation period
was extended to t = 48 h.
The primary outcome parameter was the duration of
postoperative analgesia as reflected by the TTFR. Sec-
ondary outcome measures included the onset of sensory
and motor block, NRS score for pain at rest and during
movement directly postoperatively, at t = 24 h and if ne-
cessary at t = 48 h and satisfaction score (NRS 0–10)
with the anaesthetic technique at the time of completion
of the study.
Sample size and statistical analysis
Taboada et al. [12] have reported a duration of 19 ± 3.4 h
postoperative analgesia after popliteal block with 30 mL
ropivacaine 0.75 %. Based on these data, the sample size
required to have an 80 % probability of detecting a
difference of 20 % (two-sided, level of significance 0.05)
in the duration of postoperative analgesia between the
groups was 12 patients per group. We chose to include
15 patients per group to compensate for variation in
standard deviation. Patients with specific withdrawal
criteria, as mentioned earlier in the methods section,
were withdrawn and replaced. An independent monitor
not involved in further conduction of the study made
new sealed envelopes according to group allocation of
the withdrawn patients.
Data were analysed using the GraphPad Prism 6 soft-
ware (GraphPad Software Inc, San Diego, CA). Analysis
was per protocol. The D’Agostino & Pearson omnibus
normality test was used for normality testing. Continu-
ous, normally distributed data are presented as mean ±
SD [range], non-normally distributed data as median
[interquartile range]. For statistical comparison between
the groups, the student-t test for normally distributed
data and the Mann Whitney U test for nonparametric
comparisons was used. In case a parameter is normally
distributed in one group and non-normally in the other
group, the data are presented as median [interquartile
range] and a nonparametric test used for statistical com-
parison. The Hodges-Lehmann estimate was used for
calculating the difference between population medians
with 95 % CI; the difference between each value in the
ROPI group and each value in the ROPI-EPI group was
computed and the Hodges-Lehmann estimate is the
median of this set of differences. The part of patients
without need for postoperative analgesia in group ROPI
vs ROPI-EPI were compared using Chi squared test. A
p-value < 0.05 was considered statistically significant.
Results
In order to study 15 patients in each group, 38 patients
were included in the study protocol between July 2012
and March 2013. A Consort flowchart is shown in Fig. 1.
Five patients in the ROPI group and three in the ROPI-
EPI group were withdrawn on account of specific with-
drawal criteria described in the protocol. These included
absence of the primary outcome parameter: no request
for postoperative analgesia at t = 48 h and absence of
sensory sciatic nerve block (one in each group); pain re-
quiring therapy in the distribution of the sciatic nerve
upon arrival at the recovery directly postoperatively
(block failure; three in the ROPI group, one in the
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ROPI-EPI group); and start of surgery before preopera-
tive block assessment could be made (one in each
group). The latter two patients were withdrawn from the
study because there was no time for the sciatic nerve
block to develop and the attending anesthesiologists
were allowed to use long acting opioids at their own
descretion. There were no significant differences in pa-
tient characteristics between the two groups (Table 1).
None of the patients showed signs of local anaesthetic
systemic toxicity or inadvertent intravascular injection of
epinephrine (such as rise in heart rate, systolic blood
pressure or flushing).
Due to OR logistics, block onset could not be measured
at 45 min in all patients. In case a patient did not have a
complete block before the beginning of surgery, block
success or failure was defined as absence or presence of
pain requiring therapy in the distribution of the sciatic
nerve upon arrival at the recovery directly postoperatively.
Patients with a failed block were excluded and replaced,
patients with a successful block remained in study. Table 2
shows sensory and motor block onset scores for patients
with a successful block upon arrival at the recovery.
Figure 2 shows individual TTFR data points for both
groups. Median [IQR] time to first request for postop-
erative analgesia was 463 [300–1197] min and 830
[397–1128] min for the ROPI vs. ROPI-EPI group respect-
ively. Hodges Lehman median difference between groups
was 71 min (95 % CI −415 – 473) for the ROPI-EPI vs.
ROPI group. There were no differences in any clinical out-
come measures between the groups (Table 3).
Discussion
The results of this study did not show a significant
increase in the duration of postoperative analgesia by
adding epinephrine to ropivacaine for popliteal nerve
block.
A prolonged duration of postoperative analgesia by
adding epinephrine to ropivacaine was expected based
on our clinical experience. In a previous study, we found
an indication of prolonged TTFR after the addition of
epinephrine 5 μg/mL to 450 mg ropivacaine for com-
bined sciatic/femoral nerve block for anterior cruciate
ligament reconstruction [11]. However this study was
underpowered to make comparisons in TTFR. In the
Fig. 1 Consort flowchart of patients enrolled in the study
Table 1 Patient characteristics
ROPI ROPI-EPI
Sex (M/F) 8/7 9/6
Age (yr) 61 ± 7 56 ± 11
Length (cm) 177 ± 12 175 ± 8
BMI (kg/m2) 28 ± 4 30 ± 5
ASA (I/II/III) 4/10/1 5/10/0
Surgery (*) Ankle fusion: 9 (1) Ankle fusion: 10 (3)
Subtalar fusion: 6 Subtalar fusion: 4 (1)
Combination: 0 Combination: 1
Operation time (min) 87 ± 33 92 ± 33
ROPI popliteal block with 30 mL ropivacaine 0.75 % without epinephrine, ROPI-
EPI popliteal block with 30 mL ropivacaine 0.75 % with epinephrine 5 μg/mL.
Values are proportions, mean (SD) or actual numbers. Differences between the
groups were not significant. *Patients with medial incision beside
lateral incision
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present study we were unable to confirm this expected
difference in sensory block duration. Although the dif-
ference in the median TTFR between the groups is large
(367 min), the data show a large variation and data in
group ROPI are skewed with a long tail and therefore
are not normally distributed. The Hodges Lehman esti-
mate of the median difference was 71 min (95 % CI
−415 – 473). As a result of the large variation in our
data the risk of a type II error is considerable. The
absence of a statistically significant difference should
therefore be interpreted with caution.
Our results are consistent with previous findings by
Cederholm [9] and Weber [10]. Cederholm found no
difference in duration of sensory block during epidural
analgesia with 20 mL ropivacaine 0.5 % or 0.75 % either
with or without epinephrine 5 μg/mL. Weber did not
find an effect of epinephrine 5 μg/mL added to 20 mL
ropivacaine 0.5 % and 0.2 % on postoperative analgesia
via a femoral catheter after total knee replacement.
Epinephrine is thought to prolong block duration based
on a decrease in local anaesthetic absorption due to local
vasoconstriction at the site of injection [3]. Ropivacaine
has intrinsic vasoconstrictive properties. Cederholm [13]
found an inverse dose–response relationship in which the
weakest solutions of ropivacaine (0.063 % and 0.125 %)
showed the most marked reduction in skin blood flow
measured by laser doppler as compared to normal saline.
Kopacz [14] found that subcutaneous injection of ropiva-
caine 0.25 % and 0.75 % reduced cutaneous blood flow in
pigs to a similar degree at both concentrations also mea-
sured by laser doppler. The addition of epinephrine to
ropivacaine did not alter the maximum decrease in
blood flow observed; however epinephrine significantly
decreased blood flow when added to saline.
This quality of ropivacaine may also explain the absence
of a clinical significant difference in block duration of
ropivacaine either with or without epinephrine found in
our study.
Our study has several limitations. We did not measure
block duration by assessing sensory and motor block at
regular time intervals, and TTFR is a subjective measure
of block duration. However, pin-prick assessments of
sensory block during 24-48 h, including night-time, is
bothersome for patients and, for instance, in the present
study impossible due to the post-operative cast manage-
ment. From a clinical perspective duration of analgesia is
more important than duration of sensory block. We
therefore feel that using the TTFR as a tool to measure
block duration is acceptable. Our decision to replace the
two patients (one in each group) who made no request
for pain relief during 48 h and in whom there were no
longer signs of sensory sciatic nerve block is debatable,
as it may be argued that both patients had a successful
sciatic nerve block. However, since the primary outcome
parameter (TTFR) was absent in these patients and the
sciatic nerve block had worn off, we felt it would have
been inappropriate to censor these data to 48 h and in-
clude them in the analysis.
Furthermore, anesthesiologists were not blinded for
treatment allocation. All blocks were performed by expe-
rienced anesthesiologists in a standardized fashion as
described in the treatment protocol. Since they were not
involved in block assessment or in any other way in the
conduction of the study, we believe that the absence of
Table 2 Sensory and motor nerve block at beginning of
surgery
Nerve ROPI ROPI-EPI
Complete Partial Absent Complete Partial Absent
Tibial sensory 4 11 1 9 4 2
Tibial motor 10 3 2 9 5 1
Peroneal
sensory
12 3 - 11 4 -
Peroneal motor 11 2 2 10 3 2
Groups as defined in Table 1. Values represent numbers of patients
Fig. 2 Individual data points of time to first request for postoperative
analgesia. ROPI: popliteal block with 30 mL ropivacaine 0.75 % without
epinephrine; ROPI-EPI: popliteal block with 30 mL ropivacaine 0.75 %
with epinephrine 5 μg/mL; TTFR: Time To First Request for postoperative
analgesia. Horizontal lines represent medians ± interquartile range.
Dotted lines represent t = 24 and 48 h
Table 3 Clinical outcome measures
ROPI ROPI-EPI p-value
TTFR (min) 463 [300–1197] 830 [397–1128] 0.56
NRS rest at t = 24 h 1 [0–3] 1 [1–3] 0.70
NRS movement at t = 24 h 1.5 [0–3] 2 [1–3] 0.47
NRS max during 24 h 4 [2–7] 6 [3–8] 0.17
NRS satisfaction with block 8 [8–9] 9 [8–10] 0.08
Groups as defined in Table 1. Values are median [IQR]. TTFR Time To First
Request for postoperative analgesia, NRS Numeric Rating Scores (0–10)
Schoenmakers et al. BMC Anesthesiology  (2015) 15:100 Page 5 of 6
blinding of the anesthesiologists performing the blocks
does not affect the results.
Another limitation is that we studied the duration of
analgesia of the popliteal nerve block for ankle fusion
surgery while the cutaneous sensory supply of the med-
ial malleolus is by the saphenous nerve. Clendenen and
Whalen histologically verified that the saphenous nerve
innervates not only the skin, but also the periosteum of
the medial malleolus and joint capsule [15]. Because we
performed only a single-shot femoral or saphenous nerve
block with mepivacaine, the TTFR in individual patients
may have been triggered by pain in the distribution of the
saphenous nerve, and thus reflect the duration of sensory
block of the femoral or saphenous nerve rather than the
sciatic nerve. Standard incision for ankle fusion and subta-
lar fusion is on the lateral side. However, an additional
medial incision was made in 5/30 patients. In four of these
patients the TTFR was > 360 min. Because the duration of
sensory femoral or saphenous nerve block is shorter, we
believe that the effect of pain in the distribution of the
saphenous nerve on the TTFR is minimal.
Conclusions
In conclusion, we were unable confirm an expected differ-
ence in the duration of postoperative analgesia by adding
epinephrine to ropivacaine for popliteal nerve block. This
may be explained on the basis of the intrinsic vasocon-
strictive properties of ropivacaine or due to a large vari-
ation in the individual TTFR, the absence of a significant
difference may also be caused by a type II error.
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